Breaking News Instant updates and real-time market news.

AAN

Aaron's

$58.85

2.05 (3.61%)

, BSX

Boston Scientific

$41.57

0.16 (0.39%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55

Stephens to hold a conference

2019 Stephens Nashville Investment Conference will be held in Nashville on November 13-15.

AAN

Aaron's

$58.85

2.05 (3.61%)

BSX

Boston Scientific

$41.57

0.16 (0.39%)

CBM

Cambrex

$59.86

(0.00%)

CNI

Canadian National

$93.18

0.32 (0.34%)

EA

Electronic Arts

$97.54

1.52 (1.58%)

DPZ

Domino's Pizza

$278.68

-0.555 (-0.20%)

ENSG

Ensign Group

$40.68

0.37 (0.92%)

EGOV

NIC Inc.

$23.61

0.2 (0.85%)

FIS

FIS

$135.49

1.68 (1.26%)

FDX

FedEx

$156.72

0.5 (0.32%)

EXP

Eagle Materials

$93.76

1.215 (1.31%)

EPAY

Bottomline Technologies

$46.95

0.71 (1.54%)

GKOS

Glaukos

$62.68

(0.00%)

GMS

GMS Inc.

$32.07

0.72 (2.30%)

HAL

Halliburton

$20.33

-0.29 (-1.41%)

HUM

Humana

$317.95

-0.94 (-0.29%)

JAX

J. Alexander's

$10.45

0.02 (0.19%)

JBHT

J.B. Hunt

$116.81

0.27 (0.23%)

LAD

Lithia Motors

$160.86

-0.34 (-0.21%)

LII

Lennox

$254.96

2.6 (1.03%)

LPX

Louisiana-Pacific

$29.10

-0.14 (-0.48%)

MATX

Matson

$36.65

-0.48 (-1.29%)

MOS

Mosaic

$20.30

0.61 (3.10%)

ODFL

Old Dominion

$195.17

0.58 (0.30%)

VG

Vonage

$7.68

-0.13 (-1.66%)

UNT

Unit Corp.

$0.79

-0.1114 (-12.38%)

WMT

Walmart

$120.65

-0.41 (-0.34%)

WNC

Wabash

$14.91

-0.255 (-1.68%)

RM

Regional Management

$33.09

0.31 (0.95%)

POOL

Pool Corp.

$205.52

0.74 (0.36%)

SAVE

Spirit Airlines

$37.70

0.21 (0.56%)

SLB

Schlumberger

$34.72

-0.31 (-0.88%)

SM

SM Energy

$8.88

-0.34 (-3.69%)

NTR

Nutrien

$49.30

-0.13 (-0.26%)

NOV

National Oilwell

$22.09

-0.26 (-1.16%)

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

  • 22

    Nov

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

  • 17

    Dec

  • 07

    Feb

AAN Aaron's
$58.85

2.05 (3.61%)

09/26/19
BOFA
09/26/19
INITIATION
Target $75
BOFA
Buy
Aaron's initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Jason Haas initiated Aaron's (AAN) with a Buy rating and a price target of $75. The analyst expects the company to produce "significant upside" to revenue and EPS from the large national retailer partnerships in its Progressive Leasing segment, adding that its rent-to-own contracts through Best Buy (BBY), Lowe's (LOW), Wayfair (W) and Overstock (OSTK) could more than double the company's sales and earnings over time.
09/26/19
09/26/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dropbox (DBX) assumed with an Outperform at RBC Capital. 2. Rigel Pharmaceuticals (RIGL) assumed with an Overweight at JPMorgan. 3. Aaron's (AAN) initiated with a Buy at BofA/Merrill. 4. Cooper-Standard (CPS) resumed with a Buy at Roth Capital. 5. Carvana (CVNA) initiated with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/16/19
RAJA
10/16/19
NO CHANGE
Target $80
RAJA
Strong Buy
Aaron's price target raised to $80 from $72 at Raymond James
Raymond James analyst Budd Bugatch raised his price target for Aaron's (AAN) to $80 from $72 and reiterated a Strong Buy rating following the recent news that Lowe's (LOW) had rolled out the Aaron's/Progressive virtual lease-to-own program nationwide. Bugatch tells investors in a research note that he believes this will be a terrific "win" for Progressive and create much value for Aaron's and says he can envision ~$30 in permanent incremental share value.
10/21/19
LOOP
10/21/19
NO CHANGE
Target $90
LOOP
Buy
Aaron's price target raised to $90 from $73 at Loop Capital
Loop Capital analyst Anthony Chukumba raised his price target on Aaron's (AAN) to $90 and kept his Buy rating ahead of its Q3 results on November 4th, reflecting the company's recent announcement of rolled out Progressive offering at Lowe's (LOW) nationwide. The analyst expects investors to focus on the management's earnings call commentary regarding Progressive sales and the "invoice volume per active door" growth metric, along with any updates on its partnership with Best Buy (BBY). Chukumba is also raising his FY20 EPS view on Aaron's to $4.97 from $4.54.
BSX Boston Scientific
$41.57

0.16 (0.39%)

09/03/19
LEHM
09/03/19
INITIATION
Target $48
LEHM
Overweight
Boston Scientific reinstated with an Overweight at Barclays
Barclays analyst Kristen Stewart reinstated coverage of Boston Scientific with an Overweight rating and $48 price target. With multiple new products across all of its business units, the company is well positioned to sustain high-single digit organic sales growth for the foreseeable future, Stewart tells investors in a research note. She believes the consensus view on the stock "is the right view."
09/05/19
JPMS
09/05/19
INITIATION
Target $50
JPMS
Overweight
Boston Scientific reinstated with an Overweight at JPMorgan
JPMorgan analyst Robbie Marcus reinstated coverage of Boston Scientific with an Overweight rating and $50 price target following a period of restriction. The analyst continues to see the company as a "best-in-class Large-Cap MedTech asset," with "many shots on goal" to support a multi-year premium organic sales growth trajectory of 7%-10% through 2023.
09/05/19
09/05/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. General Electric (GE) initiated with an Equal Weight at Morgan Stanley. 2. Organigram (OGI) initiated with a Perform at Oppenheimer. 3. Wingstop (WING) initiated with a Market Perform at Raymond James. 4. Boston Scientific (BSX) reinstated with an Overweight at JPMorgan. 5. Cubic (CUB) initiated with a Hold at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/19
COWN
09/20/19
NO CHANGE
Target $47
COWN
Outperform
Boston Scientific setting up well for better second half, says Cowen
Cowen analyst Joshua Jennings said Boston Scientific is setting up for a batter second half to the year as the company has a steady flow of product launches scheduled for the second half and should also experience momentum in its core businesses over that interval. In addition, there is one more selling day in the second half versus one less in the first. Jennings reiterated his Outperform rating and $47 price target on Boston Scientific shares.
CBM Cambrex
$59.86

(0.00%)

05/07/19
FANA
05/07/19
DOWNGRADE
Target $55
FANA
Outperform
Cambrex downgraded to Outperform from Strong Buy at First Analysis
First Analysis analyst Steven Schwartz downgraded Cambrex to Outperform from Strong Buy while raising his price target for the shares to $55 from $45. The company's valuation multiple is now in-line with peers following the recent share price appreciation, Schwartz tells investors in a research note. He sees less near-term upside given the expected decline in Cambrex's Gilead business through 2020 and his view that "financially significant" revenue synergies from the recent acquisitions will be realized over a mid- to longer-term time horizon.
05/07/19
05/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fluor (FLR) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revich seeing an unclear medium-term margin outlook amid the company's CEO transition and further project writedowns in Q1. 2. Gardner Denver (GDI) downgraded to Neutral from Buy at UBS with analyst Damian Karas downgraded saying the shares are due for a "breather" following the recent run. 3. Boeing (BA) downgraded to Equal Weight from Overweight at Barclays with analyst David Strauss expecting the recovery of 737 Max production to take longer than expected. 4. Discover (DFS) downgraded to Perform from Outperform at Oppenheimer with analyst Dominick Gabriele seeing limited upside in the shares following the rally year-to-date now that his estimates are in-line with the consensus. 5. Cambrex (CBM) downgraded to Outperform from Strong Buy at First Analysis with analyst Steven Schwartz saying the company's valuation multiple is now in-line with peers following the recent share price appreciation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/07/19
WBLR
08/07/19
DOWNGRADE
WBLR
Market Perform
Cambrex downgraded to Market Perform from Outperform at William Blair
William Blair analyst John Kreger downgraded Cambrex to Market Perform from Outperform and raised his price target on the stock to $60 after the company agreed to be acquired by an affiliate of the Permira funds for $60 per share in cash.
08/12/19
CHLM
08/12/19
DOWNGRADE
Target $60
CHLM
Hold
Cambrex downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Matt Hewitt downgraded Cambrex to Hold from Buy after the company announced that it is being acquired by Permira Funds for $60 per share in cash. The analyst also raised his price target on the shares to $60 from $52.
CNI Canadian National
$93.18

0.32 (0.34%)

10/24/19
LOOP
10/24/19
UPGRADE
LOOP
Buy
Canadian Pacific upgraded to Buy from Hold at Loop Capital
Loop Capital analyst Rick Paterson upgraded Canadian Pacific (CP) to Buy and raised his price target to CAD340 from CAD332. The analyst notes that the company posted a strong quarter as its operating ratio declined to 56.1% while its earnings grew by 12%. Paterson further states that Canadian Pacific generated positive volume growth in Q3, which is "unique" among its rail peers. With the "best operations and service in the industry", the analyst further justifies the upgrade as the stock is also the "cheapest" in the industry, trading at a 2-turn discount to Canadian National (CNI) and 1.5-turn discount to average U.S. rails.
10/28/19
WELS
10/28/19
INITIATION
Target $88
WELS
Market Perform
Canadian National initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Allison Poliniak-Cusic initiated coverage of Canadian National with a Market Perform rating and $88 price target.
10/29/19
WELS
10/29/19
INITIATION
Target $88
WELS
Market Perform
Canadian National initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Allison Poliniak-Cusic initiated coverage of Canadian National with a Market Perform rating and $88 price target. In a research note to investors, the analyst says railroad shares have fared well despite a challenging economic backdrop, with the shares on average performing in line with the S&P 500. Valuations are currently reflecting the near-term optimism on the efficiency gains that railroads have made and, as a result, she looks to be more selective in this environment. She says execution remains "solid" and would expect for most rails that improvement could be more moderate at current levels. Looking beyond that, Poliniak-Cusic expects that traffic trends will continue to be challenged, further putting pressure on earnings and results.
11/01/19
BMOC
11/01/19
UPGRADE
BMOC
Outperform
Canadian National upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Fadi Chamoun upgraded Canadian National Railway (CNI) to Outperform from Market Perform with a price target of C$130, up from C$123. There is a strong case to be made that the worst of the volume headwinds are here for or even behind the railroads, Chamoun tells investors in a research note. The analyst, who thinks volume growth momentum should pick up in the second half of 2020, is also upgrading his view on the rail sector. He says Canadian National Railway is a low-cost operator of a "high-quality and unique physical footprint," bringing it "durable competitive advantages and strong medium- to long-term growth fundamentals." Chamoun is reversing his September 2018 cautious call on the Railroads group. The analyst also continues to recommend Union Pacific (UNP) and Canadian Pacific (CP) with Outperform ratings. He keeps Market Perform ratings on Norfolk Southern (NSC) and Kansas City Southern (KSU).
EA Electronic Arts
$97.54

1.52 (1.58%)

10/22/19
10/22/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Electronic Arts (EA) downgraded to Equal Weight from Overweight at Barclays with analyst Deepak Mathivanan saying the shares are currently trading below the middle of their historical valuation range, but the discount is justified. 2. Main Street (MAIN) downgraded to Market Perform from Outperform at Raymond James with analyst Robert Dodd citing valuation. 3. Lloyds Banking (LYG) downgraded to Neutral from Buy at Citi with analyst Andrew Coombs saying the stocks of U.K. banks are already pricing in a more favorable Brexit outcome. 4. Textron (TXT) downgraded to Neutral from Buy at BofA/Merrill with analyst Ronald Epstein saying he was previously more constructive on signs of a recovery in the business jet end market along with stronger company operations, but now sees a "softening" end market and a more "lackluster" operating recovery. 5. Intuit (INTU) downgraded to In Line from Outperform at Evercore ISI with analyst Kirk Materne citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/19
PIPR
10/30/19
NO CHANGE
Target $106
PIPR
Overweight
Electronic Arts price target lowered to $106 from $112 at Piper Jaffray
Piper Jaffray analyst Michael Olson lowered his price target for Electronic Arts to $106 from $112 but maintains an Overweight rating on the shares. The company reported September quarter results that were ahead of consensus based on strong live services revenue, and while fiscal 2020 guidance was increased, it remains below consensus, Olson tells investors in a research note. The analyst, however, is not surprised that Electronic Arts is "remaining somewhat conservative" with guidance ahead of its busiest quarter.
10/30/19
BARD
10/30/19
NO CHANGE
Target $108
BARD
Outperform
Electronic Arts results overshadowed by pipeline concerns, says Baird
Baird analyst Colin Sebastian said Electronic Arts delivered solid Q results but he feels its report was overshadowed by out-year pipeline concerns. He said the pipeline shift raises questions about 2021 growth as management confirmed the next installment of its key Battlefield franchise will not ship until 2022. He noted Live Services showed impressive growth but mobile remained a relative weak spot. Sebastian reiterated his Outperform rating and lowered his price target to $108 from $114 on Electronic Arts shares.
10/30/19
SPHN
10/30/19
NO CHANGE
Target $120
SPHN
Overweight
Stephens remains buyer on EA weakness ahead of new 'Star Wars' game
Stephens analyst Jeff Cohen maintained an Overweight rating and $120 price target on Electronic Arts after the company delivered a beat-and-raise Q2 "driven by live services and EA Sports." Cohen noted, however, that investors will be focused on the announcement that the game maker will not have its expected "Battlefield" release next year but rather in fiscal 2022. The analyst said he believes it is the right move for the franchise and will allow the next "Battlefield" to launch into a larger installed base of new consoles in FY22. While this does put "significantly" more emphasis on live services and changes the earnings algorithm for fiscal 2021, Cohen said he sees a number of potential areas for revenue upside including Volta monetization, "Apex" in China on Steam, and "Star Wars" story downloadable content, and thus he remains a buyer ahead of "what should be a strong" release of "Star Wars Jedi: Fallen Order" on November 15.
DPZ Domino's Pizza
$278.68

-0.555 (-0.20%)

10/23/19
KING
10/23/19
INITIATION
KING
Neutral
Domino's Pizza initiated with a Neutral at CL King
CL King analyst Todd Brooks initiated coverage of Domino's Pizza with a Neutral citing short-term headwinds.
10/23/19
10/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Golden Entertainment (GDEN) initiated with an Overweight at JPMorgan. 2. Endava (DAVA) initiated with a Positive at Susquehanna. 3. Verint (VRNT) initiated with a Buy at Needham. 4. Papa John's (PZZA) initiated with a Buy at CL King while Domino's Pizza (DPZ) was initiated with a Neutral. 5. Oportun Financial (OPRT) initiated with an Outperform at JMP Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/31/19
MAXM
10/31/19
NO CHANGE
Target $305
MAXM
Buy
Domino's Pizza price target raised to $305 from $280 at Maxim
Maxim analyst Stephen Anderson raised his price target on Domino's Pizza to $305 and kept his Buy rating, saying the disappointing results from GrubHub (GRUB) and Pizza Hut reported this week suggest that competitive threats to the company are "overstated". The analyst expects Domino's Pizza to accelerate its comps growth and buybacks over the next 6-12 months, boosting his FY20 EPS view by 24c to $11.24 and his FY21 view by 30c to $13.36.
11/04/19
COWN
11/04/19
NO CHANGE
Target $295
COWN
Outperform
Domino's Pizza comps lowered on decelerating delivery trends, says Cowen
Cowen analyst Andrew Charles lowered his comps on Domino's Pizza (DPZ) as he grew concerned about a potential deceleration in delivery trends and GrubHub's (GRUB) plans to accelerate $0 delivery free promos in Q4. GrubHub's plans throw cold water on any hopes for moderation in the promotional environment. The analyst sees the GrubHub situation more problematic near-term than longer term. Charles maintained his Outperform rating and $295 price target on Domino's Pizza shares.
ENSG Ensign Group
$40.68

0.37 (0.92%)

10/10/19
RHCO
10/10/19
NO CHANGE
Target $330
RHCO
Hold
SunTrust 'bullish' across healthcare services space ahead of Q3 results
SunTrust analyst David MacDonald says he remains "bullish" across much of the healthcare services space ahead of third quarter results, citing "solid" core trends, "attractive" secular tailwinds, "robust" M&A and "strong" free cash flow. While he expects ongoing intermittent "chop" as industry noise continues to weigh, he views the risk of meaningful structural change as quite low, continues to favor scaled, integrated providers in the ongoing shift towards value and views valuation risk/rewards as increasingly attractive. The analyst tells investors in a research note that he does not necessarily view Q3 results as a meaningful trigger and thinks improved visibility around the election and Democratic primary is key, MacDonald remains bullish on core fundamentals, sees significant inherent sector drivers and says Managed Care remains a favorite fundamental sector. The analyst raised his price target for Anthem (ANTM) to $330 from $290, on Centene (CNC) to $80 from $72, on Cigna (CI) to $260 from $230, on Humana (HUM) to $340 from $310, on Molina (MOH) to $180 from $165, on UnitedHealth (UNH) to $330 from $310, on WellCare (WCG) to $340 from $320, on Ensign Group (ENSG) to $60 from $44 and Tivity Health (TVTY) to $24 from $21.
10/21/19
SPHN
10/21/19
INITIATION
Target $45
SPHN
Equal Weight
Ensign Group resumed with an Equal Weight at Stephens
Stephens analyst Scott Fidel resumed coverage of Ensign Group with an Equal Weight rating and $45 price target. He views Ensign as a best-in-class operator, but the skilled nursing facility vertical has experienced a challenging operating environment and the mix shift to MA in Medicare could add further long-term pressure, Fidel said.
10/31/19
STFL
10/31/19
UPGRADE
Target $51
STFL
Buy
Ensign Group upgraded to Buy from Hold at Stifel
Stifel analyst Chad Vanacore upgraded Ensign Group (ENSG) to Buy from Hold after the company provided 2020 guidance that points to accelerating growth. Given the company's continuing real estate acquisitions and its agreement with Pennant Group (PNTG) to fund future senior living acquisitions, Vanacore said he sees a potential real estate spin-off or sale on the horizon. Vanacore lowered his price target on Ensign to $51 from $56.
10/31/19
10/31/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lowe's (LOW) upgraded to Overweight from Equal Weight at Barclays with analyst Karen Short saying total comp expectations for Q3 may be too high due to the expected drag from Canada as well as ongoing weakness in e-commerce, but believe the U.S. comp estimate of 3.6% "is what matters and is more achievable." 2. Sony (SNE) upgraded to Buy from Neutral at UBS. 3. Ensign Group (ENSG) upgraded to Buy from Hold at Stifel with analyst Chad Vanacore saying he sees a potential real estate spin-off or sale on the horizon. 4. Lyft (LYFT) upgraded to Buy from Neutral at Goldman Sachs with analyst Heath Terry saying the company reported better than expected Q3 revenue and management noted a trend toward higher prices across the industry, incremental engagement per rider, and a less promotional competitive environment. 5. Brinker (EAT) upgraded to Overweight from Neutral at Piper Jaffray with analyst Nicole Miller Regan saygin the company's return to EBITDA growth should drive a re-rating of the multiple. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EGOV NIC Inc.
$23.61

0.2 (0.85%)

05/07/19
LOOP
05/07/19
UPGRADE
Target $22
LOOP
Buy
NIC Inc. upgraded to Buy from Hold at Loop Capital
Loop Capital analyst Joseph Vafi upgraded NIC Inc. to Buy from Hold and raised his price target for the shares to $22 from $16. The company is seeing its strongest same-state growth in years, Vafi tells investors in a research note following the company's Q1 results.
08/01/19
DADA
08/01/19
UPGRADE
Target $21
DADA
Buy
NIC Inc. upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Peter Heckmann upgraded NIC Inc to Buy and raised his price target to $21 from $18 after its Q2 earnings beat. The analyst notes that the company is "securing several new contracts" while approaching the anniversary loss of a portion of the Texas contract, which he expects to boost investor sentiment on the stock.
09/17/19
DADA
09/17/19
DOWNGRADE
DADA
Neutral
NIC Inc. downgraded to Neutral from Buy at DA Davidson
09/17/19
09/17/19
DOWNGRADE
Target $21

Neutral
NIC Inc. downgraded to Neutral from Buy at DA Davidson
As previously reported, DA Davidson analyst Peter Heckmann downgraded NIC Inc to Neutral and maintained his $21 price target. With the stock price exceeding his price target, the analyst is citing valuation in the downgrade following a 70% year-to-date run up in its stock price, even though he sees the company generating a solid growth trend starting in Q4 after securing several new contract in the first half of 2019 and with the anniversary of the loss of a part of its Texas contract. Heckmann contends that further "material" move in the stock price would require an announcement of new contract wins or accretive M&A.
FIS FIS
$135.49

1.68 (1.26%)

09/16/19
BARD
09/16/19
NO CHANGE
Target $158
BARD
Outperform
FIS designated a Fresh Pick at Baird
Baird analyst David Koning names FIS as a Fresh Pick as he believes its underperformance gives it the potential to be 26-29% higher a year from now. The analyst sees potential for higher earnings and improving leverage. Koning raised his price target to $158 from $145 on FIS shares.
10/14/19
UBSW
10/14/19
INITIATION
Target $139
UBSW
Neutral
FIS initiated with a Neutral at UBS
UBS analyst Eric Wasserstrom initiated coverage of FIS with a Neutral rating and $139 price target.
10/18/19
RHCO
10/18/19
NO CHANGE
Target $125
RHCO
Buy
Fiserv price target raised to $125 from $110 at SunTrustF
SunTrust analyst Andrew Jeffrey raised his price target on Fiserv (FISV) to $125 and kept his Buy rating, saying there is "material upside" for the company's earnings and free cash flows. The analyst notes that the stock price features about a 10% EBITDA discount relative to its peer Fidelity National (FIS) that is likely driven by the lagging organic revenue growth of its Global Business Solutions, but he believes that "detractors" are not focusing on the company's superior free cash flows. Jeffrey adds that the two stocks should trade closer to parity because of their comparable long-term organic revenue growth and Fiserve's "more cohesive" capital returns.
11/11/19
BTIG
11/11/19
UPGRADE
Target $95
BTIG
Buy
Q2 Holdings upgraded to Buy from Neutral at BTIG
BTIG analyst Mark Palmer upgraded Q2 Holdings (QTWO) to Buy from Neutral with a $95 price target, saying the recent pullback in the stock price offers an attractive entry point given the company's takeout target potential. The analyst notes that Q2 Holdings has built a track record around leveraging its online and mobile SaaS banking platform to help North America financial institutions to upgrade their outdated online and mobile banking offerings. Palmer adds that the company has now "rapidly evolved" by competing aggressively for the business of Tier 1 financial institutions. The analyst further states that Q2 Holdings has become more of a threat to larger competitors Jack Henry (JKHY), Fiserv (FISV) and FIS (FIS).
FDX FedEx
$156.72

0.5 (0.32%)

10/09/19
10/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Domino's Pizza (DPZ) downgraded to Hold from Buy at Argus with analyst John Staszak citing its worse than expected Q3 revenue and earnings along with its new 2-3 year outlook of global retail sales growth of 7%-10% - down from its prior 3-5 year outlook of 8%-12% growth. 2. FedEx (FDX) downgraded to Market Perform from Outperform at Bernstein. 3. Waters (WAT) downgraded to Underweight from Equal Weight at Barclays with analyst Jack Meehan saying as leading indicators of the macro environment continue to weaken, he sees risk to the outlook for Waters' Industrial sales exposure. 4. iRobot (IRBT) downgraded to Underperform from Market Perform at Raymond James with analyst Brian Gesuale saying he thinks Street models aren't reflecting the beginning of a meaningful commoditization cycle across the RVC category. 5. Lincoln Electric (LECO) downgraded to Hold from Buy at Stifel with analyst Nathan Jones saying he still sees Lincoln Electric as "one of the highest quality businesses" in his coverage universe thanks to its strong management and leading technologies, but believes that the headwinds in the company's end market will limit the upside for investors in the near term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/19
BREN
10/11/19
NO CHANGE
Target $155
BREN
Hold
FedEx price target lowered to $155 from $175 at Berenberg
Berenberg analyst William Howard lowered his price target for FedEx to $155 from $175 while keeping a Hold rating on the shares. Despite blaming its fourth profit warning in a year on global macroeconomics, it is clear that FedEx "is facing a cocktail of difficulties," Howard tells investors in a research note. These include the "grinding" integration of TNT Express, managing $900M of annualized lost revenue from Amazon, slowing industrial growth in the U.S., and the upcoming shift to seven-day delivery in its U.S. Ground business, says the analyst.
10/28/19
WELS
10/28/19
INITIATION
Target $189
WELS
Outperform
FedEx initiated with an Outperform at Wells Fargo
Wells Fargo analyst Allison Poliniak-Cusic initiated coverage of FedEx with an Outperform rating and $189 price target.
10/29/19
WELS
10/29/19
INITIATION
Target $189
WELS
Outperform
Wells Fargo says FY20 could be trough in earnings for FedEx
Wells Fargo analyst Allison Poliniak-Cusic initiated coverage of FedEx with an Outperform rating and $189 price target. In a research note to investors, the analyst says she believes shares have well priced the issues of lower volumes in Express from international weakness, ongoing issues with the TNT integration and increased expenses from investments into the shares and sees upside potential to shares based on the view that FY20 could prove to be the trough in earnings as the TNT integration moves toward completion, international demand stabilizes or inflects higher when/if a trade agreement materializes, and FedEx grows into its recent investments, acting as catalysts for the shares.
EXP Eagle Materials
$93.76

1.215 (1.31%)

09/20/19
NRCS
09/20/19
UPGRADE
NRCS
Neutral
Eagle Materials upgraded to Neutral from Sell at Northcoast
10/09/19
EXAN
10/09/19
INITIATION
Target $112
EXAN
Outperform
Eagle Materials initiated with an Outperform rating at Exane BNP Paribas
Exane BNP Paribas initiated Eagle Materials with an Outperform and $112 price target.
11/04/19
DADA
11/04/19
NO CHANGE
Target $94
DADA
Neutral
Eagle Materials price target raised to $94 from $85 at DA Davidson
DA Davidson analyst Brent Thielman raised his price target on Eagle Materials to $94 after its Q2 earnings beat, also raising his FY20 EBITDA forecast to $430M from $414M to reflect improved Cement volume and significant share repurchases year-to-date. The analyst still keeps his Neutral rating on Eagle Materials however, noting that the current multiples for its business in his sum-of-the-parts model suggests "insufficient upside" for the stock.
11/13/19
JEFF
11/13/19
NO CHANGE
JEFF
Continental Building buyout modest negative for Eagle Materials, says Jefferies
Jefferies analyst Philip Ng views Continental Building Products (CBPX) takeover by Saint-Gobain (CODYY) as a "very good outcome" for Continental shareholders. The analyst also views the deal as a modest negative for Eagle Materials (EXP), noting that its "two most logical acquirers" are now "out of the picture." However, the "outsized" valuation Continental Building extracted likely props up the value of Eagle Materials' wallboard assets in the public markets, Ng tells investors in a research note.
EPAY Bottomline Technologies
$46.95

0.71 (1.54%)

08/09/19
CHLM
08/09/19
UPGRADE
Target $52
CHLM
Buy
Bottomline Technologies upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst George Sutton upgraded Bottomline Technologies to Buy from Hold and raised his price target to $52 from $49 following the company's Q4 earnings report. In a research note to investors, Sutton points out the fact that Bottomline's 28% growth in TTM Subscription & Transaction bookings should nicely support a reacceleration of revenue, adding that the $18.4M of backlog in the Digital Banking segment should be implemented in the back half of FY20.
08/09/19
BRRR
08/09/19
NO CHANGE
BRRR
Outperform
Bottomline Technologies 'remains undervalued', says Barrington
Barrington analyst Gary Prestopino kept his Outperform rating on Bottomline Technologies with a price target in the $60-$65 target range after its Q4 results, saying the below-consensus Q1 guidance was negatively impacted by FX. The analyst notes that the quarter still saw "strong success" in bookings and continued product innovation, helping the company grow its subscription and transaction revenues by 15%-20%. Prestopino further states that the stock remains undervalued, which is underscored by its recently announced $50M stock buyback.
09/26/19
DADA
09/26/19
NO CHANGE
Target $42
DADA
Neutral
Bottomline Technologies price target raised to $42 from $39 at DA Davidson
DA Davidson analyst Peter Heckmann raised his price target on Bottomline Technologies to $42 to reflect his model changes following review of the company's 10-K filing and the slightly improved FX basket, even though he sees those factors as "immaterial". The analyst is keeping his Neutral rating on the stock, noting that the company's bookings are losing momentum following a "strong" 2018, adding that he will also continue to monitor the impact of Brexit uncertainty given Bottomline Technologies' "significant" UK operations.
11/12/19
SBSH
11/12/19
NO CHANGE
SBSH
Buy
Citi added Bottomline Technologies to 'Value Creators' Focus List
Citi strategist Scott Chronert added Bottomline Technologies to his firm's "Value Creators" Focus List. The company's recent quarterly reports suggests its fundamentals have stabilized, with management confidence in mid-to-upper teens subscription revenue growth ahead, Chronert tells investors in a research note. Citi analyst Andrew Schmidt has a Buy rating on shares of Bottomline Technologies.
GKOS Glaukos
$62.68

(0.00%)

08/26/19
JPMS
08/26/19
NO CHANGE
Target $90
JPMS
Overweight
Glaukos selloff brings 'notable buying opportunity,' says JPMorgan
JPMorgan analyst Robbie Marcus sees a "notable buying opportunity" following the post-earnings weakness in shares of Glaukos (GKOS). Fundamentals in the underlying business remain strong, the company's pipeline of products remains solid, and management remains confident in the Avedro (AVDR) deal, Marcus tells investors in a research note. He sees a "highly favorable" risk/reward for shares of Glaukos entering late 2019 and 2020. The analyst keeps an Overweight rating on the shares with a $90 price target.
09/12/19
PIPR
09/12/19
NO CHANGE
Target $80
PIPR
Overweight
Piper says buy Glaukos as Avedro deal has 'homerun potential'
Piper Jaffray analyst Matt O'Brien believes Glaukos' (GKOS) acquisition of Avedro (AVDR) has "homerun potential." In the near-term, Avedro should quadruple Glaukos' total addressable market to $4B and accelerate its revenue growth in 2020, "plugging the gap ahead of iDose," O'Brien tells investors in a research note following a deep dive analysis. Longer term, Glaukos is "putting together the pieces of what could become an ophthalmology powerhouse," addressing a potential opportunity of greater than $40B, adds the analyst. He "strongly" encourages investors to take a look at the Glaukos story today as he sees at least $80 per share of value in just the base businesses alone. O'Brien reiterates an Overweight rating on the shares with an $80 price target.
09/30/19
BOFA
09/30/19
DOWNGRADE
Target $67
BOFA
Underperform
Glaukos downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Bob Hopkins double downgraded Glaukos (GKOS) to Underperform from Buy and lowered his price target for the shares to $67 from $75. The analyst remains bullish on the company's long term prospects and sees no issues with its Q3 and Q4 results, but he prefers other names in the space given the potential distraction associated with the integration of Avedro. Hopkins also lowered his price target for ShockWave Medical (SWAV) to $40 from $64 and for Intersect ENT (XENT) to $22 from $39.
10/24/19
SPHN
10/24/19
NO CHANGE
Target $95
SPHN
Overweight
Glaukos could benefit from Allergan's 'unfortunate' XEN hold, says Stephens
Stephens analyst Chris Cooley noted Allergan's (AGN) initiation earlier this week of a voluntary recall of affected lots of XEN 45 and precautionary temporary product hold. Though XEN usage is reserved for moderate to severe cases of POAG, the "unfortunate" temporary hold may create additional opportunities for Glaukos (GKOS) to train and convert glaucoma specialists to iStent inject, contends Cooley. The analyst, who said he remains confident in Glaukos' ability to achieve low-teens percentage MIGS growth in calendar 2020, keeps an Overweight rating on Glaukos shares.
GMS GMS Inc.
$32.07

0.72 (2.30%)

08/30/19
GHSC
08/30/19
NO CHANGE
Target $33
GHSC
Buy
GMS Inc. price target raised to $33 from $28 at Seaport Global
Seaport Global analyst Matt McCall raised his price target for GMS Inc. to $33 from $28 saying the company reported fiscal Q2 results that exceeded estimates despite continued pressure on its single-family housing business in Canada. The market is realizing more and more that the risks from pressures in the Canadian housing market are more modest than feared, McCall tells investors in a post-earnings research note. He sees the quarter as supporting the stock's valuation recovery and reiterates a Buy rating on GMS.
08/30/19
RHCO
08/30/19
NO CHANGE
Target $32
RHCO
Buy
GMS Inc price target raised to $32 from $23 at SunTrust
SunTrust analyst Keith Hughes raised his price target on GMS to $32 and kept his Buy rating after its Q1 earnings beat, saying most of the company's metrics topped expectations in spite of the "very weak" Canada business acquired in June of last year. The analyst notes that GMS' U.S. business generated "good" revenue growth in mid-single digits, while the company's overall organic sales were also up by 3.4%. Hughes expects the back half of FY20 to show similar results with easier comps expected for the Canada operations.
08/30/19
RBCM
08/30/19
NO CHANGE
Target $30
RBCM
Outperform
GMS Inc price target raised to $30 from $23 at RBC Capital
RBC Capital analyst Mike Dahl raised his price target on GMS to $30 and kept his Outperform rating after its Q1 earnings beat. The analyst says the company's core organic growth remained "solid" with wallboard pricing coming in "more resilient" than he expected. Dahl also raises his FY20 organic growth outlook for GMS' Wallboard segment to +1% from -1% and its Ceilings segment to 5% from 4%, even though he sees the organic growth outlook for the Steel sector as weaker. The analyst adds that the company's free cash flow strength seen in Q1 along with its more stable pricing trends warrant a higher multiple for the stock.
11/13/19
RHCO
11/13/19
NO CHANGE
Target $37
RHCO
Hold
Continental Building price target raised to $37 from $26 at SunTrust
SunTrust analyst Keith Hughes raised his price target on Continental Building (CBPX) to $37 after the company announced it is being acquired by St. Gobain at that price. The analyst notes that the manufacturer consolidation is a positive for pricing discipline, helping other distributors like GMS Inc (GMS) and Foundation Building Materials (FBM).
HAL Halliburton
$20.33

-0.29 (-1.41%)

10/22/19
COWN
10/22/19
NO CHANGE
Target $27
COWN
Outperform
Halliburton guidance better than feared, says Cowen
Cowen analyst Marc Bianchi noted Halliburton outpaced the group index with its Q3 results which saw a slight operational miss. The analyst said the Q4 guidance was better than feared and was positive on the new aggressive capacity rationalization and cost cutting program. He thinks the show of discipline is positive for the group and he expects similar commentary as others report however, he believes a bottom in activity needs to be more visible before a true inflection can occur. Bianchi maintained his Outperform rating and lowered his price target to $27 from $28 on Halliburton shares.
10/22/19
STFL
10/22/19
NO CHANGE
Target $26
STFL
Buy
Halliburton results and outlook included some underlying positives, says Stifel
Stifel analyst Stephen Gengaro noted that Halliburton's Q3 results missed his forecast, but he highlights a few underlying positives in the results and outlook, including the fact that Completion & Production (C&P) margins beat his forecast despite lower than expected revenue, the Q4 guidance for C&P further suggests a positive impact from Halliburton's new U.S. land playbook and the fact that the company is limiting capital spending and he believes it can achieve an annualized $300M in cost reductions over the next several quarters. Gengaro lowered his price target for Halliburton shares to $26 from $28 based on his revised 2020 EBITDA expectations but keeps a Buy rating on the stock, which he continues to see as undervalued.
10/23/19
ARGS
10/23/19
DOWNGRADE
ARGS
Hold
Halliburton downgraded to Hold from Buy at Argus
10/23/19
ARGS
10/23/19
DOWNGRADE
ARGS
Hold
Halliburton cut to Hold at Argus on weaker near-term outlook
Argus analyst Bill Selesky downgraded Halliburton to Hold and also lowered his FY19 EPS view to $1.26 from $1.42 after the company's Q3 results and FY20 EPS view to $1.50 from $2.22 from higher tax rate assumptions next year. The analyst sees a weaker near-term outlook for Halliburton as it faces pressure from rising crude oil inventories and moderating global demand. Selesky notes that the price of oil was driven higher thanks in part to the recent attacks on the Saudi infrastructure, but believes that it will decline in the near term.
HUM Humana
$317.95

-0.94 (-0.29%)

10/17/19
MZHO
10/17/19
INITIATION
MZHO
Buy
Humana initiated with a Buy at Mizuho
10/18/19
MZHO
10/18/19
INITIATION
Target $316
MZHO
Buy
Humana initiated with a Buy at Mizuho
Mizuho analyst Ann Hynes last night initiated coverage of Humana with a Buy rating and $316 price target. The analyst sees high long-term earnings visibility given underlying market growth, the company's leading market position in Medicare, growth and margin expansion potential in Medicare Advantage, potential market share gains in Medicaid, and its diversification into healthcare services.
11/07/19
RHCO
11/07/19
NO CHANGE
Target $335
RHCO
Hold
Humana price target raised to $335 from $310 at SunTrust
SunTrust analyst David MacDonald raised his price target on Humana to $335 after its "attractive" Q3 results yesterday, highlighted by strength in its core Medicare Advantage business and headway being made in cost management. The analyst keeps his Hold rating on Humana given the balanced risk-reward at current valuation but believes that the company's "integrated offering continues to resonate", saying its growing portfolio of healthcare services position it as a "differentiator" in the industry.
11/13/19
COWN
11/13/19
NO CHANGE
Target $340
COWN
Outperform
Humana management meetings strengthened conviction, says Cowen
Cowen analyst Charles Ryhee said meeting with Humana management strengthened conviction that Humana is well positioned in individual and Group MA. The analyst said its Healthcare Services growth is a bit of a wildcard next year depending on how PDP transitions/terminations related to the new low cost plan shake out, but he but he believes the company should grow membership in 2021. Ryhee reiterated his Outperform rating and $340 price target on Humana shares.
JAX J. Alexander's
$10.45

0.02 (0.19%)

JBHT J.B. Hunt
$116.81

0.27 (0.23%)

10/16/19
FBCO
10/16/19
NO CHANGE
Target $106
FBCO
Neutral
J.B. Hunt price target raised to $106 from $101 at Credit Suisse
Credit Suisse analyst Allison Landry raised her price target for J.B. Hunt to $106 from $101 following quarterly results. The analyst notes that Q3 results were softer than expected, but "far from terrible." Landry reiterates a Neutral rating on the shares.
10/17/19
ARGS
10/17/19
NO CHANGE
ARGS
Hold
Challenging conditions at J.B. Hunt to persist, says Argus
Argus analyst John Eade is keeping his Hold rating on J.B. Hunt after its Q3 results, saying that while earnings rose 18% from last year, they still missed expectations. The analyst notes that the company's management has focused on improving its intermodal segment which had been hampered by soft demand and high inventory levels, but he expects the "challenging conditions" to persist for several more quarters. Eade adds however that he would consider upgrading the stock to Buy if volumes start to improve or if the price falls toward the $100 per share support.
11/01/19
GSCO
11/01/19
DOWNGRADE
Target $115
GSCO
Neutral
J.B. Hunt downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Jordan Alliger downgraded J.B. Hunt to Neutral from Buy with an unchanged price target of $115. The analyst cites valuation for the downgrade following the past few months of share price outperformance. The stock is fairly valued relative to J.B. Hunt's next 12-month outlook, Alliger tells investors in a research note.
11/01/19
11/01/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HP Enterprise (HPE) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster citing valuation. 2. Penn National (PENN) downgraded to Hold from Buy at Jefferies with analyst David Katz saying management has been clear in their intention is to focus on leverage reduction, which could include the sale of remaining owned assets. 3. J.B. Hunt (JBHT) downgraded to Neutral from Buy at Goldman Sachs withh analyst Jordan Alliger citing valuation. 4. Pinterest (PINS) downgraded to Hold from Buy at Pivotal Research with analyst Michael Levine saying the company's deceleration in U.S. advertising in Q3 and implied deceleration based on guidance for Q4 "was far more than we had hoped for." 5. Booking Holdings (BKNG) downgraded to Neutral from Buy at BofA/Merrill with analyst Justin Post saying the stock price is up 19% year-to-date, even though the macro concerns for the online travel industry have been "well publicized." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LAD Lithia Motors
$160.86

-0.34 (-0.21%)

09/13/19
BOFA
09/13/19
DOWNGRADE
BOFA
Neutral
Asbury Automotive, Adient, Aptiv cut to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst John Murphy is taking a "more neutral stance" on the automotive sector to reflect the greater market and macro uncertainty and also cites numerous "swing factors" that include trade and technical issues, even though some of the stocks in the auto group have already come down to "trough valuations". The analyst downgrades Asbury Auto (ABG), Adient (ADNT), and Aptiv (APTV) from Buy to Neutral, and also cuts Lithia Motors (LAD) and Sonic Auto (SAH) from Neutral to Underperform.
10/24/19
GUGG
10/24/19
NO CHANGE
Target $171
GUGG
Buy
Lithia Motors price target raised to $171 from $147 at Guggenheim
Guggenheim analyst Ali Faghri said Lithia Motors reported "impressive" Q3 results with broad-based upside and thinks growth is sustainable. Faghri sees $15 in earnings power in sight over the next few years, which is still not reflected in the stock's valuation. The analyst raising estimates following the quarterly report and increased the price target on Lithia shares to $171 from $147.
10/24/19
CHLM
10/24/19
NO CHANGE
Target $200
CHLM
Buy
Lithia Motors price target raised to $200 from $145 at Craig-Hallum
Craig-Hallum analyst Steve Dyer raised his price target for Lithia Motors to $200 from $145 as its core business continues to fire on all cylinders with omni-channel initiatives "nicely complementing." Further, the analyst believes the company is an "earnings powerhouse" that should continue to re-rate higher. He reiterates a Buy rating on the shares.
11/14/19
MSCO
11/14/19
UPGRADE
Target $31
MSCO
Equal Weight
Sonic Automotive upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley analyst Armintas Sinkevicius upgraded Sonic Automotive (SAH) to Equal Weight from Underweight with a price target of $31, up from $22, after raising his estimate for the U.S. auto seasonally adjusted annual rate in 2020 to 16.5M from 16.0M. The environment remains constructive in the near-term given lower interest rates, used car prices at record levels and credit availability, the analyst said. He also raised his price targets across the traditional auto dealers group by an average of 14%. Sinkevicius upped his target for Asbury Automotive (ABG) to $114 from $95, raised his target for AutoNation (AN) to $46 from $42, ,increased his target for Group 1 Automotive (GPI) to $128 from $105 and raised his target for Lithia Motors (LAD) to $188 from $151.
LII Lennox
$254.96

2.6 (1.03%)

10/07/19
SPHN
10/07/19
DOWNGRADE
Target $122
SPHN
Equal Weight
Stephens downgrades Ingersoll-Rand, cuts estimates for EE/MI group due to macro
As previously reported, Stephens analyst Rob McCarthy downgraded Ingersoll-Rand (IR) to Equal Weight from Overweight. McCarthy modestly trimmed his estimates for Ingersoll-Rand for FY19 and FY20, as he sees incremental concern for growth and sustainability of the HVAC cycle, and lowered his price target on the stock to $122, down from $124. He also lowered his estimates across the Electrical Equipment and Multi-Industry group due to the delaying of business capital expenditure decisions that has been caused by macro deceleration and geopolitical uncertainty. He also cut his adjusted EPS forecasts for Rockwell Automation (ROK) for FY19 and FY20, though he keeps an Overweight rating on the stock. Overall in the group, McCarthy said he is "particularly concerned" about A.O. Smith (AOS), Lennox (LII) and Regal Beloit (RBC), on which he has Equal Weight ratings.
10/21/19
WBLR
10/21/19
NO CHANGE
WBLR
Outperform
Lennox Q3 earnings 'better than feared,' says William Blair
William Blair analyst Ryan Merkel maintained an Outperform rating on Lennox, noting that Q3 results and guidance "met lowered expectations," and fears about worse Q4 guidance "did not materialize." The analyst added that "residential sales were significantly impacted by cooler weather in the Upper Midwest and Northeast," and recommended buying Lennox on "one-time weather weakness." Merkel said he sees upside in Lennox shares to $285.
10/22/19
WELS
10/22/19
NO CHANGE
Target $255
WELS
Market Perform
Lennox price target lowered to $255 from $265 at Wells Fargo
Wells Fargo analyst Saravana Raghavan lowered his price target for Lennox to $255 from $265 following quarterly results. The analyst reiterates a Market Perform rating on the shares.
10/23/19
JPMS
10/23/19
NO CHANGE
Target $200
JPMS
Underweight
Lennox price target lowered to $200 from $225 at JPMorgan
JPMorgan analyst Stephen Tusa lowered his price target for Lennox International to $200 from $225 saying the company's Q3 results reinforce his "increasingly negative view." There appears to be a reversal of the "decade long narrative of Lennox as a best in class share gainer in an extended cycle driving outperforming earnings growth supported partly by incremental capital deployment," Tusa tells investors in a research note. The company is struggling to regain market share, contends Tusa, who struggles to see much earnings growth next year as the industry slows and insurance benefits go away. The analyst keeps an Underweight rating on Lennox shares.
LPX Louisiana-Pacific
$29.10

-0.14 (-0.48%)

10/02/19
LBOW
10/02/19
DOWNGRADE
LBOW
Neutral
Louisiana-Pacific downgraded to Neutral from Buy at Longbow
Longbow analyst Garik Shmois downgraded Louisiana-Pacific to Neutral from Buy without a price target. Oriented strand board pricing hasn't accelerated as quickly as we previously anticipated, Shmois tells investors in a research note. As a result, the analyst believes catalysts for Louisiana-Pacific shares are pushed out a few quarters heading into the seasonally slow part of the year.
10/02/19
10/02/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Charles Schwab (SCHW), TD Ameritrade (AMTD), and E-Trade (ETFC) double-downgraded to Underweight from Overweight at Barclays. 2. Monster Beverage (MNST) downgraded to Neutral from Buy at Guggenheim with analyst Laurent Grandet citing his view that the stock will be range-bound until the market can better gauge the impact of the upcoming U.S. launch of Coca-Cola (KO) Energy, which is planned for January. 3. Vermilion Energy (VET) downgraded to Sector Perform from Outperform at National Bank. 4. Activision Blizzard (ATVI) downgraded to Underperform from Market Perform at Bernstein with analyst Todd Juenger saying he cannot reconcile the current stock price with the company's risk-adjusted fundamentals. 5. Louisiana-Pacific (LPX) downgraded to Neutral from Buy at Longbow with analyst Garik Shmois saying oriented strand board pricing hasn't accelerated as quickly as we previously anticipated. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/06/19
RBCM
11/06/19
NO CHANGE
Target $35
RBCM
Top Pick
Louisiana-Pacific price target raised to $35 from $30 at RBC Capital
RBC Capital analyst Paul Quinn raised his price target on Louisiana-Pacific to $35 and kept his Top Pick rating after its Q3 earnings beat and affirmed SmartSide Strand growth target of 10% in 2019. The analyst notes that after the decline in commodity oriented strand board, or OSB, pricing weighed heavily on profitability this year, he sees the setup for pricing entering 2020 as "very strong". Quinn adds that he sees the industry operating rates increasing to about 97% in 2020 from 89% in 2019.
11/06/19
BMOC
11/06/19
NO CHANGE
Target $34
BMOC
Outperform
Louisiana-Pacific price target raised to $34 from $28 at BMO Capital
BMO Capital analyst Ketan Mamtora raised his price target on Louisiana-Pacific to $34 and kept his Outperform rating after its Q3 results. The analyst notes that while the company missed on EBITDA, he expects the 10% reduction in oriented strand board, or OSB, supply and improving housing conditions to boost industry operating rates. Mamtora adds he is positive on solid growth in SmartSide volumes against "static housing demand" and "strong" balance sheet at Louisiana-Pacific.
MATX Matson
$36.65

-0.48 (-1.29%)

11/20/18
STFL
11/20/18
DOWNGRADE
STFL
Hold
Matson downgraded to Hold from Buy at Stifel
11/20/18
11/20/18
DOWNGRADE
Target $43

Hold
Matson downgraded to Hold on fading Chinese tailwind at Stifel
As previously reported, Stifel analyst Benjamin Nolan downgraded Matson to Hold from Buy citing his expectation for momentum to slow related to container volumes from China. Also, following a tour of logistics companies in Hawaii, Nolan tells investors that "Hawaii is good but not great" and he expects demand growth from that "critical segment" to be only modest, not a catalyst for the shares. Nolan maintains his $43 price target on Matson shares.
02/25/19
SPHN
02/25/19
UPGRADE
Target $44
SPHN
Overweight
Matson upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Jack Atkins upgraded Matson to Overweight and raised his price target for the shares to $44 from $40. While 2019 will be a transition year, Matson is nearing the end of its Hawaii fleet transition which brings improved efficiency and flexibility to its network, Atkins tells investors in a research note. Further, the transition will yield cost savings in fiscal 2020 and increased operating leverage, adds the analyst. He views Matson as a "defensive name" with "compelling" EBITDA and cash flow growth potential.
MOS Mosaic
$20.30

0.61 (3.10%)

10/25/19
CLVD
10/25/19
NO CHANGE
CLVD
CF Industries, Mosaic estimates lowered at Cleveland Research
Cleveland Research analyst Mike Piken lowered his FY19 estimates for both CF Industries (CF) and Mosaic (MOS) to reflect the fact that phosphate market conditions have continued deteriorating and he sees increased odds of an average to worse fall fertilizer application season in the U.S. Piken has Neutral ratings on both stocks.
11/06/19
JPMS
11/06/19
DOWNGRADE
Target $20
JPMS
Neutral
Mosaic downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Mosaic to Neutral from Overweight with a $20 price target.
11/06/19
JPMS
11/06/19
DOWNGRADE
Target $20
JPMS
Neutral
JPMorgan downgrades Mosaic, sees better entry points ahead
JPMorgan analyst Jeffrey Zekauskas downgraded Mosaic to Neutral from Overweight with a price target of $20, down from $24. The analyst "substantially" reduced his EBITDA forecast for Mosaic in 2020 due to weak pricing dynamics in both potash and phosphate fertilizers. The company is "worthwhile long-term investment," but more appropriate entry points into the shares can be achieved in the coming months, Zekauskas tells investors in a research note.
11/13/19
JPMS
11/13/19
DOWNGRADE
Target $18
JPMS
Underweight
Mosaic downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Mosaic to Underweight from Neutral with a price target of $18, down from $20. The analyst says his 2020 EBITDA forecast for Mosaic of $1.56B is about 15% lower than the Street consensus as he assumes lower potash and phosphate returns for Mosaic. He believes the domestic phosphate market did decline in 2019, which has led to low prices in the U.S. because of weak supply/demand balances.
ODFL Old Dominion
$195.17

0.58 (0.30%)

09/27/19
BOFA
09/27/19
DOWNGRADE
Target $166
BOFA
Underperform
BofA/Merrill downgrades Old Dominion to Underperform with shares near highs
BofA/Merrill analyst Ariel Rosa downgraded Old Dominion Freight Line to Underperform from Neutral with an unchanged price target of $166. Despite continued softness in a variety of economic indicators, shares of Old Dominion have traded near all-time highs in recent weeks, Rosa tells investors in a research note. The analyst sees limited further near-term upside and points out that the company's mid-quarter update showed less-than-truckload daily shipments down 4.0% year-over-year in August. This puts Old Dominion on track to miss the analyst's prior down 1.8% estimate for Q3 daily shipment volume.
10/25/19
STFL
10/25/19
DOWNGRADE
Target $155
STFL
Sell
Old Dominion downgraded to Sell from Hold at Stifel
Stifel analyst David Ross downgraded Old Dominion Freight Line to Sell from Hold with a price target of $155, up from $148. The company reported another sub-80% operating ratio in an environment where freight was down year-over-year, which is good news, Ross tells investors in a research note. However, the bad news, says the analyst, is that its earnings per share of $2.05 fell short of the Street consensus estimate of $2.11. With the stock at an all-time high, the shares have more downside than upside over the next 12 months, contends Ross. He prefers to buy the shares of "this best-in-class company again lower at a more reasonable value."
10/25/19
KEYB
10/25/19
NO CHANGE
Target $215
KEYB
Overweight
Old Dominion price target raised to $215 from $175 at KeyBanc
KeyBanc analyst Todd Fowler raised his price target for Old Dominion to $215 from $175 and maintained an Overweight rating, saying he is "encouraged" with margin performance amidst lower tonnage, with stabilizing trends and resilient pricing incremental positives. Fowler tells investors in a research note that intermediately, share and margin opportunities are seemingly on track, with balance sheet support for network investment and capital deployment.
10/29/19
ARGS
10/29/19
NO CHANGE
Target $205
ARGS
Buy
Old Dominion price target raised to $205 from $180 at Argus
Argus analyst John Eade raised his price target on Old Dominion to $205 and kept his Buy rating after its Q3 results, saying that while earnings just missed consensus, he remains positive on the company's "solid pricing" and expense control trends. The analyst further cites the management commentary on Old Dominion earnings call, noting that the demand environment saw some softness, but business trends may be picking up.
VG Vonage
$7.68

-0.13 (-1.66%)

08/06/19
JEFF
08/06/19
NO CHANGE
Target $17
JEFF
Buy
Vonage price target raised to $17 from $15 at Jefferies
Jefferies analyst John DiFucci raised his price target on Vonage to $17 and kept his Buy rating after its Q2 earnings beat and above-consensus Q3 outlook, saying the company is starting to show a "trend of strong execution". The analyst says the API platform revenue accelerated, with growth driven by continued expansion beyond SMS APIs into voice, video, Verify, and chat.
09/03/19
KEYB
09/03/19
INITIATION
Target $17
KEYB
Overweight
Vonage initiated with an Overweight at KeyBanc
KeyBanc analyst Alex Kurtz started Vonage Holdings with an Overweight rating and $17 price target. Vonage is reaching an inflection point with mid-market and enterprise customers that is driving improved monthly recurring revenue and should lead to a positive bias to Street estimates, Kurtz tells investors in a research note. He believes the company has transformed into a leading unified communications as a service and communications platform as a service vendor. The analyst admits, however, that Vonage's debt load and cash levels are likely to cap its near-term multiple.
09/19/19
MSCO
09/19/19
INITIATION
Target $15
MSCO
Equal Weight
Vonage initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Meta Marshall started Vonage Holdings with an Equal Weight rating and $15 price target. The analyst believes Vonage has done an "excellent job" building a full unified communications platform over the past five years. However, expectations need to be reset on margins and EBITDA growth in order for the shares to see meaningful appreciation, Marshall tells investors in a research note.
11/07/19
SBSH
11/07/19
NO CHANGE
Target $12.5
SBSH
Buy
Vonage price target lowered to $12.50 from $16 at Citi
Citi analyst Michael Rollins lowered his price target for Vonage Holdings to $12.50 from $16 after the company's Q3 results came in below expectations and it lowered guidance for Business Revenue growth and adjusted OIBDA. The analyst, however, remains a buyer of the shares and keeps a Buy rating on the name. He believes Vonage's "value gap supports future upside."
UNT Unit Corp.
$0.79

-0.1114 (-12.38%)

12/13/18
RAJA
12/13/18
DOWNGRADE
RAJA
Unit Corp. downgraded to Market Perform from Strong Buy at Raymond James
Raymond James analyst J. Marshall Adkins double downgraded Unit Corp. to Market Perform from Strong Buy due to expectations of softer 2019 production growth and a reduced oil price deck. Adkins is now modeling Unit's 2019 production growth at 6.9% versus 8.7% previously and is revising down his active rig count assumptions to 31 from 37 rigs.
12/20/18
SOCO
12/20/18
DOWNGRADE
SOCO
Equalweight
Unit Corp. downgraded to Equalweight from Overweight at Capital One
10/15/19
RAJA
10/15/19
NO CHANGE
Target $37
RAJA
Strong Buy
Raymond James sees 'disappointing' quarter for oil services market
Raymond James analyst Praveen Narra previewed the Oilfield Services space, telling investors in a research note that he expects Q3 to be another disappointing quarter for the oil services market as activity plunged throughout the quarter. The weakness in the quarter was apparent from June, but was exacerbated by September's steep activity decline that was far more pronounced than expected, Narra says, adding that it appears "unlikely" that Q4 will offer a reprieve from pain, and is more likely to accelerate due to E&P budget exhaustion. The analyst expects consensus estimates to decline further through earnings season. He lowered his price target for Cactus, Inc (WHD) to $37 from $40, for Halliburton (HAL) to $32 from $37, for National Oilwell Varco (NOV) to $28 from $34, for Newpark Resources to $10 from $12, for Nine Energy Service (NINE) to $11 from $15, for Patterson-UTI Energy (PTEN) to $12 from $17, for Oil States International (OIS) to $20 from $23, for Unit Corp (UNT) to $8 from $14 and for USA Compression to $20 from $21.
11/08/19
RAJA
11/08/19
DOWNGRADE
RAJA
Market Perform
Unit Corp. downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded Unit Corp. to Market Perform from Outperform.
WMT Walmart
$120.65

-0.41 (-0.34%)

11/04/19
OPCO
11/04/19
NO CHANGE
Target $125
OPCO
Perform
Walmart price target raised to $125 from $108 at Oppenheimer
Oppenheimer analyst Rupesh Parikh raised his price target for Walmart to $125 from $108 ahead of the Q3 print, saying he has "warmed" towards the company's improving prospects throughout the year, but valuation has kept him sidelined. Parikh, who maintains a Perform rating, says he sees continued market share gains from grocery omni-channel efforts and the ongoing rationalization of the U.S. retail sector, but does not see enough upside to justify an Outperform rating at these levels.
11/07/19
NOMU
11/07/19
INITIATION
Target $132
NOMU
Buy
Walmart initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Michael Baker initiated coverage of Walmart with a Buy rating and $132 price target. The analyst cites the company's share gains in stores and online, especially in the grocery sector. Baker adds that Walmart is well positioned to take advantage of a favorable consumer backdrop but can also outperform in a weaker economic environment based on its "defensive" profile.
11/12/19
BARD
11/12/19
NO CHANGE
Target $130
BARD
Outperform
Baird senses 'upward bias' to Walmart Q3 EPS expectations
Ahead of Walmart's report of Q3 earnings on Thursday before the open, Baird analyst Peter Benedict said he senses an "upward bias" to EPS expectations given the company's "solid" Q2 comps, trends improving across the quarter and several initiatives to help sustain momentum. While he expects some sequential moderation in U.S. comps during Q4, Benedict thinks consensus expectations already reflect this and believes continued progress on expenses suggest good support for consensus Q4 EPS expectations. He reiterates an Outperform rating and $130 price target on Walmart shares.
11/14/19
BARD
11/14/19
NO CHANGE
Target $130
BARD
Outperform
Baird says positive thesis on Walmart reinforced by Q3 report
Baird analyst Peter Benedict said Walmart's Q3 adjusted earnings beat and FY19 guidance raise reinforce his positive thesis on the stock, calling out continued strong U.S. comps, robust U.S. e-commerce growth and positive year-over-year underlying operating profit growth as "key highlights." He notes that Walmart's U.S. comps are expected to moderate in Q4, as its guidance implies same-store sales growth for the segment of about 2.5%, but said this is already reflected in consensus expectations. Benedict, in his "early read" note, maintained an Outperform rating and $130 price target on Walmart shares.
WNC Wabash
$14.91

-0.255 (-1.68%)

07/19/19
OTRG
07/19/19
DOWNGRADE
OTRG
Negative
Wabash downgraded to Negative from Mixed at OTR Global
07/19/19
07/19/19
DOWNGRADE

Negative
Update: Wabash downgraded to Negative following checks at OTR Global
As previously reported, OTR Global downgraded Wabash to Negative from Mixed. The firm's checks indicate trailer dealer expectations for 2019 heavy-duty trailer sales have deteriorated significantly since April due to weak demand, increased cancellations, and softer freight rates.
07/31/19
CHLM
07/31/19
DOWNGRADE
CHLM
Hold
Wabash downgraded to Hold from Buy at Craig-Hallum
08/01/19
08/01/19
DOWNGRADE
Target $18

Hold
Wabash downgraded to Hold at Craig-Hallum
As previously reported, Craig-Hallum analyst Steve Dyer downgraded Wabash to Hold from Buy, with a $18 price target. While the analyst acknowledges the company's "strong" results, he believes the industry is becoming more challenging.
RM Regional Management
$33.09

0.31 (0.95%)

02/21/19
BTIG
02/21/19
INITIATION
Target $36
BTIG
Buy
Regional Management initiated with a Buy at BTIG
BTIG analyst Giuliano Bologna initiated Regional Management with a Buy rating and a price target of $36, calling the stock a "compelling growth story with high ROE, low leverage and future potential". With a "strong track record of growing receivables", the analyst contends that Regional Management will be able to grow its EPS by an annualized 17.1% over the next 2 years without adding to its leverage.
05/09/19
JANY
05/09/19
UPGRADE
Target $36
JANY
Buy
Regional Management upgraded to Buy from Neutral at Janney Montgomery Scott
Janney Montgomery Scott analyst John Rowan upgraded Regional Management to Buy from Neutral and raised his price target for the shares to $36 from $34.
POOL Pool Corp.
$205.52

0.74 (0.36%)

07/18/19
WBLR
07/18/19
NO CHANGE
WBLR
Outperform
Pool Corp. should be bought on any earnings selloff, says William Blair
William Blair analyst Ryan Merkel recommends using any post-earnings weakness in shares of Pool Corp. as a buying pool opportunity. The "slight" EBITDA miss is due to unfavorable weather while demand remains "firm," Merkel tells investors in a research note. He keeps an Outperform rating on Pool Corp. following this morning's Q2 results.
08/23/19
SIDC
08/23/19
DOWNGRADE
Target $215
SIDC
Neutral
Pool Corp. downgraded to Neutral from Buy at Sidoti
Sidoti analyst Anthony Lebiedzinski downgraded Pool Corp. to Neutral from Buy, stating that he sees limited upside to his $215 price target following the stock's 30% advance over the past 12 months. He attributes the outperformance to generally better than expected top- and bottom-line results as well as Pool's "attractive recurring revenue stream."
08/23/19
08/23/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HP Inc. (HPQ) downgraded In Line at Evercore ISI. 2. Macy's (M) downgraded to Neutral from Buy at Guggenheim. 3. L Brands (LB) downgraded to Sector Perform from Outperform at RBC Capital with analyst Kate Fitzsimons saying she thinks Victoria's Secret product and marketing efforts into second half 2019 will take longer tin inflect the business than outlined by management's 2019 outlook. 4. Triumph Group (TGI) downgraded to Underweight from Equal Weight at Barclays with analyst David Strauss saying he doesn't foresee meaningful free cash flow over the next several years, estimating annual free cash flow well below $100M through FY22. 5. Pool Corp. (POOL) downgraded to Neutral from Buy at Sidoti with analyst Anthony Lebiedzinski saying he sees limited upside to his $215 price target following the stock's 30% advance over the past 12 months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/18/19
BARD
10/18/19
NO CHANGE
Target $230
BARD
Outperform
Pool Corp. price target raised to $230 from $192 at Baird
Baird analyst David Manthey raised his price target on Pool Corp. to $230 from $192 after reporting in-line core Q3 results. The analyst said the company's newer capacity-creating initiatives are showing good early progress. He continues to view Pool as a best-in-class operator deserving of a premium multiple and he would be a more aggressive buyer on any pullbacks. Manthey reiterated his Outperform rating on Pool Corp. shares.
SAVE Spirit Airlines
$37.70

0.21 (0.56%)

09/23/19
09/23/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alcoa (AA) downgraded to Neutral from Buy at Goldman Sachs. 2. Commercial Metals (CMC) was downgraded to Neutral from Buy at Goldman Sachs while Schnitzer Steel (SCHN) was downgraded to Sell from Neutral. 3. AK Steel (AKS) was downgraded to Underweight from Overweight at JPMorgan while Cleveland-Cliffs (CLF) and U.S. Steel (X) were downgraded to Neutral from Overweight. 4. Clorox (CLX) downgraded to Underweight from Equal Weight at Barclays. 5. Spirit Airlines (SAVE) downgraded to Equal Weight from Overweight at Stephens with analyst Jack Atkins saying with its heavy Southeast and Caribbean exposure, Spirit significantly lowered its Q3 guidance in early September due to Hurricane Dorian. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/21/19
BUCK
10/21/19
NO CHANGE
Target $88
BUCK
Buy
Alaska Air price target raised to $88 from $78 at Buckingham
Buckingham analyst Daniel McKenzie raised his price target for Alaska Air (ALK) to $88 from $78 and lowered his price target for American Airlines (AAL) to $42 from $43. He maintained Buy ratings on both airline names ahead of Q3 earnings this week. In a research note to investors, McKenzie says the industry is set to deliver Q3 pre-tax profits of $5.8B, up 16.5% year-over-year, primarily on top line revenue growth. The analyst believes Alaska Air, American Airlines, Hawaiian Holdings (HA) and JetBlue (JBLU) are most likely to outperform on revenue and EPS execution, while he thinks Spirit Airlines (SAVE) is the most likely to disappoint.
10/31/19
SBSH
10/31/19
INITIATION
Target $46
SBSH
Buy
Spirit Airlines initiated with a Buy at Citi
Citi analyst Stephen Trent initiated coverage of Spirit Airlines with a Buy rating and $46 price target.
10/31/19
SBSH
10/31/19
INITIATION
SBSH
Citi initiates the U.S. airlines sector, says Delta is top pick
Citi analyst Stephen Trent initiated the U.S. airlines sector in a note titled "Initiating coverage: Pick Your Routes Carefully." The analyst initiated Delta (DAL), United Airlines (UAL), and Spirit Airlines (SAVE) with Buy ratings, Southwest (LUV) with a Neutral rating, and American Airlines (AAL) with a Sell rating. Trent said that Delta was his top pick, citing attractive revenue diversity, relatively smooth earnings streams, and solid alliance networks. Trent is Neutral on Southwest as he believes the company's valuation relative to growth, along with 737 MAX risks, put the shares near fair value. The analyst has a Sell on American Airlines due to the company's high leverage, 2020 MAX redeployment, pilot contract negotiations, and valuations concerns.
SLB Schlumberger
$34.72

-0.31 (-0.88%)

09/16/19
LEHM
09/16/19
UPGRADE
Target $50
LEHM
Overweight
Schlumberger upgraded to Overweight from Equal Weight at Barclays
Barclays analyst J. David Anderson upgraded Schlumberger to Overweight from Equal and raised his price target for the shares to $50 from $45.
09/16/19
LEHM
09/16/19
UPGRADE
Target $50
LEHM
Overweight
Barclays upgrades Schlumberger after new CEO 'hit all the right notes'
Barclays analyst J. David Anderson upgraded Schlumberger to Overweight from Equal and raised his price target for the shares to $50 from $45. New CEO Olivier Le Peuch "hit all the right notes" as he repositions the company to succeed in a lower growth environment, Anderson tells investors in a research note. The analyst believes Le Peuch addressed the Street's biggest concerns while also providing "bold, yet achievable" financial targets. Anderson thinks long-only investors will start to pay attention after gaining confidence in the new direction of Schlumberger. The company is now best positioned among the Big 3, says the analyst.
09/16/19
SBSH
09/16/19
NO CHANGE
SBSH
Nabors, Schlumberger, Halliburton have material operations in Saudi, says Citi
Following the attacks on Saudi Arabia, Citi analyst Scott Gruber expects "most if not all" of the Upstream Energy complex could see an uplift. However, Nabors Industries (NBR), Schlumberger (SLB), Halliburton (HAL) and Valaris (VAL) have material operations in Saudi and could see activity slow given the magnitude of the outage, Gruber tells investors in a research note.
09/16/19
09/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Raytheon (RTN) upgraded to Overweight from Neutral at JPMorgan with analyst Seth Seifman saying the stock's outperformance thus far in September is a sign of increasing investor confidence in the outlook for Raytheon and for the United Technologies (UTX) combination, along with some mean reversion. 2. Uber (UBER) and Lyft (LYFT) upgraded to Buy from Hold at HSBC. 3. Schlumberger (SLB) upgraded to Overweight from Equal Weight at Barclays with analyst J. David Anderson saying new CEO Olivier Le Peuch "hit all the right notes" as he repositions the company to succeed in a lower growth environment. 4. RE/MAX Holdings (RMAX) upgraded to Outperform from Market Perform at JMP Securities. 5. Esperion (ESPR) upgraded to Neutral from Sell at Goldman Sachs with analyst Paul Choi saying he now sees less risk of the launch performance of bempedoic acid disappointing over the intermediate term since 2019-2022 consensus revenue estimates have come down "meaningfully." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SM SM Energy
$8.88

-0.34 (-3.69%)

07/30/19
07/30/19
INITIATION
Target $10

Hold
SM Energy initiated with a Hold at SunTrust
As previously reported, SunTrust analyst Neal Dingmann initiated SM Energy with a Hold rating and a price target of $10. The analyst believes the company will outspend the cash flows from its "highly uniform" oil & gas assets by about $127M over the remainder of this year and sees zero to low single digit ROCE over the next 2 years. Dingmann adds that he needs to see a "material" cash flow to bring SM Energy's leverage to "comfort level."
09/16/19
KEYB
09/16/19
UPGRADE
Target $14
KEYB
Overweight
SM Energy upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Leo Mariani upgraded SM Energy to Overweight from Sector Weight with a price target of $14 citing the company's exposure to higher oil prices.
10/10/19
GHSC
10/10/19
DOWNGRADE
GHSC
Neutral
SM Energy downgraded to Neutral from Buy at Seaport Global
10/10/19
GHSC
10/10/19
DOWNGRADE
GHSC
Neutral
Seaport Global cuts SM Energy to Neutral among 13 E&P downgrades
As previously reported, Seaport Global analyst Mike Kelly downgraded SM Energy to Neutral from Buy. The rating change was among 13 downgrades made in the E&P sector by Kelly, who contends that "the 2020 oil macro set up is a mess." On SM specifically, he does not see free cash flow over the next two years and views the company's debt and leverage as an issue.
NTR Nutrien
$49.30

-0.13 (-0.26%)

08/16/19
BOFA
08/16/19
NO CHANGE
BOFA
BofA/Merrill shakes up ratings in chemicals space with 2 upgrades, 4 downgrades
BofA Merrill Lynch analyst Steve Byrne said it appears that risks of U.S. economic contagion from the broader global macro slowdown are "steadily building." Given this view, he has generally moved to be more cautious on the earnings outlook and ratings for stocks with global industrial exposure, resulting in his upgrade of two chemicals stocks and his downgrades of four others. Byrne downgraded Dow Inc. (DOW) to Underperform from Neutral and Westlake Chemical (WLK) to Underperform from Buy, noting their commodity exposure. He downgraded Axalta Coating (AXTA) to Neutral from Buy and cut PPG (PPG) to Underperform from Neutral as he is getting more cautious about their revenue prospects. He upgraded Venator Materials (VNTR) to Buy from Underperform, citing what he views as an attractive risk-reward as he expects earnings will grow in 2020, driven by product upgrades and productivity initiatives. Byrne also upgraded Nutrien (NTR) to Neutral from Underperform as he believes Ag stocks could prove to be defensive plays.
09/18/19
SBSH
09/18/19
NO CHANGE
SBSH
Citi lowers estimates for fertilizer names while keeping Buy ratings
Citi analyst P.J. Juvekar lowered his estimates for the fertilizer names while maintaining Buy ratings on CF Industries (CF), Mosaic (MOS) and Nutrien (NTR). The analyst, who reduced his 2019 earnings estimates by ~15% and 2020 earnings estimates by ~6%, remains at the low end of Street estimates for 2019. The third quarter is proving to be tough in fertilizers, especially phosphates, Juvekar tells investors in a research note. He lowered his price target for CF to $57 from $59 while keeping a $27 price target on Mosaic and $61 target on Nutrien.
09/23/19
CEDG
09/23/19
INITIATION
Target $67
CEDG
Overweight
Nutrien initiated with an Overweight at Consumer Edge
Consumer Edge initiated Nutrien with an Overweight and $67 price target.
10/31/19
SBSH
10/31/19
NO CHANGE
Target $103
SBSH
Buy
Citi names FMC top pick in Ag, boosts target to $103 from $98
Citi analyst P.J. Juvekar raised his price target for FMC Corporation (FMC) to $103 from $98 saying the company reported "an all-round robust quarter," with growth across most geographies and segments. FMC is now the analyst's top pick in Agriculture, followed by Nutrien (NTR) then CF Industries (CF). He keeps a Buy rating on FMC. Ag chemicals is a better market than fertilizers, which tend to be commoditized, Juvekar tells investors in a research note.
NOV National Oilwell
$22.09

-0.26 (-1.16%)

09/05/19
09/05/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Outperform from Perform at Oppenheimer with analyst Timothy Horan saying the company's fundamentals are "healthy" in the near-term, and 2020 is setting up to be a "strong year." 2. Activision Blizzard (ATVI) upgraded to Overweight from Equal Weight at Stephens with analyst Jeff Cohen citing his view that estimates for 2019 are now "de-risked" due to the successful launch of World of Warcraft Classic and the announcement of a Nintendo Switch port of Overwatch. 3. Match Group (MTCH) upgraded to Buy from Hold at SunTrust with analyst Youssef Squali saying that the "positive" intra-quarter app traffic and revenue trends imply a positive quarter-to-date momentum for the company. 4. Incyte (INCY) upgraded to Outperform from Market Perform at JMP Securities and to Outperform from Perform at Oppenheimer. 5. National Oilwell (NOV) upgraded to Buy from Hold at Jefferies with analyst Bradley Handler saying even with the uncertain macro environment, National Oilwell's outlook includes backlog-based growth potential and less margin risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/19
GSCO
10/30/19
UPGRADE
Target $33
GSCO
Buy
National Oilwell upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Angie Sedita upgraded National Oilwell to Buy from Neutral with a price target of $33, up from $29. The analyst raised her estimates to reflect the company's revenue growth and cost cutting. Further, National Oilwell's exposure to international and offshore markets is offsetting North America softness, Sedita tells investors in a research note. She believes the company is "determined" to further reduce costs at the segment level as it right sizes the business for a new operating environment.
10/30/19
10/30/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Outperform from Market Perform at Bernstein with analyst Aaron Gal saying that the controversy is solidly around aducanumab. 2. Nu Skin (NUS) upgraded to Hold from Sell at Stifel with analyst Mark Astrachan saying while he thinks trends in China, which makes up 33% of sales, will likely remain negative for the foreseeable future, he now thinks they are unlikely to worsen. 3. Microchip (MCHP) upgraded two notches to Strong Buy from Market Perform at Raymond James while Analog Devices (ADI) was upgraded to Outperform from Market Perform. 4. National Oilwell (NOV) upgraded to Buy from Neutral at Goldman Sachs with analyst Angie Sedita citing the company's revenue growth and cost cutting. 5. AMD (AMD) upgraded to Buy from Hold at Loop Capital and CFRA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

03:10
12/16/19
12/16
03:10
12/16/19
03:10
General news
FX Update: »

FX Update: The dollar…

03:05
12/16/19
12/16
03:05
12/16/19
03:05
General news
Asian Market Update: »

Asian Market Update:…

MRPLY

Mr Price Group

$0.00

(0.00%)

20:14
12/15/19
12/15
20:14
12/15/19
20:14
Upgrade
Mr Price Group rating change at JPMorgan »

Mr Price Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$341.67

-4.795 (-1.38%)

18:48
12/15/19
12/15
18:48
12/15/19
18:48
Periodicals
Boeing considering halting or cutting 737 MAX production, WSJ reports »

Boeing (BA) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XEL

Xcel Energy

$62.27

0.91 (1.48%)

18:42
12/15/19
12/15
18:42
12/15/19
18:42
Initiation
Xcel Energy initiated at Goldman Sachs »

Xcel Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQUA

Evoqua Water

$19.53

-0.6 (-2.98%)

18:38
12/15/19
12/15
18:38
12/15/19
18:38
Recommendations
Evoqua Water analyst commentary at Stifel »

Evoqua Water price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLSFY

Bluescope Steel

$0.00

(0.00%)

18:33
12/15/19
12/15
18:33
12/15/19
18:33
Upgrade
Bluescope Steel rating change at JPMorgan »

Bluescope Steel upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLSFY

Bluescope Steel

$0.00

(0.00%)

16:54
12/15/19
12/15
16:54
12/15/19
16:54
Upgrade
Bluescope Steel rating change at Macquarie »

Bluescope Steel upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$72.82

0.23 (0.32%)

16:36
12/15/19
12/15
16:36
12/15/19
16:36
Recommendations
Stifel adds Sage to Select List, says SAGE-217 will generate billions »

Stifel analyst Paul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DD

DuPont

$64.79

-1.39 (-2.10%)

16:10
12/15/19
12/15
16:10
12/15/19
16:10
Earnings
DuPont sees 2019 operating EBITDA at low end of guidance range »

DuPont reconfirms its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

IFF

$134.01

-0.55 (-0.41%)

16:07
12/15/19
12/15
16:07
12/15/19
16:07
Earnings
IFF affirms existing 2019 guidance for sales and earnings »

IFF is affirming its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

IFF

$134.01

-0.55 (-0.41%)

16:05
12/15/19
12/15
16:05
12/15/19
16:05
Hot Stocks
IFF, DuPont unit see revenue growth in mid-single digits over long term »

The company created by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$103.99

1.085 (1.05%)

, MAT

Mattel

$13.35

0.58 (4.54%)

16:03
12/15/19
12/15
16:03
12/15/19
16:03
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

HAS

Hasbro

$103.99

1.085 (1.05%)

MAT

Mattel

$13.35

0.58 (4.54%)

FNKO

Funko

$15.16

0.23 (1.54%)

JAKK

JAKKS Pacific

$0.94

-0.0244 (-2.54%)

BBW

Build-A-Bear

$2.70

-0.05 (-1.82%)

MAS

Masco

$47.00

-0.44 (-0.93%)

FBHS

Fortune Brands

$65.09

-0.42 (-0.64%)

SPY

SPDR S&P 500 ETF Trust

$317.27

0.13 (0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

IFF

$134.01

-0.55 (-0.41%)

16:03
12/15/19
12/15
16:03
12/15/19
16:03
Hot Stocks
IFF to merge with DuPont's Nutrition & Biosciences unit via Reverse Morris Trust »

IFF (IFF) and DuPont (DD)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$134.01

-0.55 (-0.41%)

, DD

DuPont

$64.79

-1.39 (-2.10%)

15:58
12/15/19
12/15
15:58
12/15/19
15:58
Hot Stocks
Breaking Hot Stocks news story on International Flavors, DuPont »

DuPont to receive…

IFF

International Flavors

$134.01

-0.55 (-0.41%)

DD

DuPont

$64.79

-1.39 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$134.01

-0.55 (-0.41%)

, DD

DuPont

$64.79

-1.39 (-2.10%)

15:58
12/15/19
12/15
15:58
12/15/19
15:58
Hot Stocks
Breaking Hot Stocks news story on International Flavors, DuPont »

DuPont holders will own…

IFF

International Flavors

$134.01

-0.55 (-0.41%)

DD

DuPont

$64.79

-1.39 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$134.01

-0.55 (-0.41%)

, DD

DuPont

$64.79

-1.39 (-2.10%)

15:57
12/15/19
12/15
15:57
12/15/19
15:57
Recommendations
International Flavors, DuPont analyst commentary  »

International Flavors to…

IFF

International Flavors

$134.01

-0.55 (-0.41%)

DD

DuPont

$64.79

-1.39 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILL

Bill.com

$38.59

3.09 (8.70%)

, EH

Ehang

$12.87

0.39 (3.13%)

15:25
12/15/19
12/15
15:25
12/15/19
15:25
On The Fly
Opening Day: XP finishes first week higher, Sprout Social lower »

This past week saw six…

BILL

Bill.com

$38.59

3.09 (8.70%)

EH

Ehang

$12.87

0.39 (3.13%)

HCCO

Healthcare Merger Corp.

$0.00

(0.00%)

OCFT

OneConnect

$10.08

(0.00%)

SPT

Sprout Social

$16.76

(0.00%)

XP

XP

$37.61

3.235 (9.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$67.60

0.285 (0.42%)

, SCOR

comScore

$4.63

-0.41 (-8.13%)

15:09
12/15/19
12/15
15:09
12/15/19
15:09
Hot Stocks
Sony's 'Jumanji' tops weekend box office with $60.1M in sales »

Sony's (SNE)…

SNE

Sony

$67.60

0.285 (0.42%)

SCOR

comScore

$4.63

-0.41 (-8.13%)

DIS

Disney

$146.37

0.4 (0.27%)

LGF.A

Lionsgate

$9.68

-0.315 (-3.15%)

LGF.B

Lionsgate

$9.00

-0.35 (-3.74%)

T

AT&T

$38.24

-0.11 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

DLTR

Dollar Tree

$93.59

1.04 (1.12%)

, DG

Dollar General

$154.75

-0.885 (-0.57%)

14:31
12/15/19
12/15
14:31
12/15/19
14:31
Periodicals
Local governments want dollar stores selling fresh food, WSJ reports »

Local governments across…

DLTR

Dollar Tree

$93.59

1.04 (1.12%)

DG

Dollar General

$154.75

-0.885 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELUXY

Electrolux

$0.00

(0.00%)

14:25
12/15/19
12/15
14:25
12/15/19
14:25
Hot Stocks
Electrolux sees $70M charge in Q4 from North America consolidation »

Electrolux provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$9.74

0.655 (7.21%)

, BP

BP

$36.95

-0.005 (-0.01%)

10:39
12/15/19
12/15
10:39
12/15/19
10:39
Recommendations
Barclays, BP, Amadeus IT Group, Anglo American, BT Group, Carlsberg, Demant, E.ON, Intertek, Novartis, Persimmon, Puma, RSA Insurance, Koninklijke Vopak, Hammerson, NMC Health, Reckitt Benckiser, Renault analyst commentary  »

Jefferies gives European…

BCS

Barclays

$9.74

0.655 (7.21%)

BP

BP

$36.95

-0.005 (-0.01%)

AMADY

Amadeus IT Group

$0.00

(0.00%)

NGLOY

Anglo American

$0.00

(0.00%)

BT

BT Group

$0.00

(0.00%)

CABGY

Carlsberg

$0.00

(0.00%)

WILYY

Demant

$0.00

(0.00%)

EONGY

E.ON

$0.00

(0.00%)

IKTSY

Intertek

$0.00

(0.00%)

NVS

Novartis

$93.00

-0.055 (-0.06%)

PSMMY

Persimmon

$0.00

(0.00%)

PUMSY

Puma

$0.00

(0.00%)

RSNAY

RSA Insurance

$0.00

(0.00%)

VOPKY

Koninklijke Vopak

$0.00

(0.00%)

HMSNF

Hammerson

$0.00

(0.00%)

NMHLY

NMC Health

$0.00

(0.00%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 23

    Mar

SNE

Sony

$67.60

0.285 (0.42%)

, SCOR

comScore

$4.63

-0.41 (-8.13%)

05:55
12/15/19
12/15
05:55
12/15/19
05:55
Hot Stocks
Sony's 'Jumanji' tops weekend box office with $60.1M in sales »

Sony's (SNE)…Reference Link

SNE

Sony

$67.60

0.285 (0.42%)

SCOR

comScore

$4.63

-0.41 (-8.13%)

DIS

Disney

$146.37

0.4 (0.27%)

LGF.A

Lionsgate

$9.68

-0.315 (-3.15%)

LGF.B

Lionsgate

$9.00

-0.35 (-3.74%)

T

AT&T

$38.24

-0.11 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

, AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

04:55
12/15/19
12/15
04:55
12/15/19
04:55
Conference/Events
Roth Capital to hold a conference »

8th Annual ROTH Deer…

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

BBSI

Barrett Business

$93.18

1.82 (1.99%)

BNGO

Bionano Genomics

$1.02

0.01 (0.99%)

IRMD

iRadimed

$25.25

-0.52 (-2.02%)

FC

Franklin Covey

$35.21

-0.57 (-1.59%)

NBEV

New Age Beverages

$1.91

-0.015 (-0.78%)

WATT

Energous

$1.99

(0.00%)

EAST

Eastside Distilling

$2.79

-0.12 (-4.12%)

DCTH

Delcath Systems

$0.00

(0.00%)

BOOM

DMC Global

$52.89

0.64 (1.22%)

CLAR

Clarus

$13.47

-0.02 (-0.15%)

JRSH

Jerash Holdings

$6.46

(0.00%)

MCHX

Marchex

$3.68

0.03 (0.82%)

JYNT

Joint Corp.

$17.37

0.28 (1.64%)

SOLY

Soliton

$10.35

-0.005 (-0.05%)

SMSI

Smith Micro

$4.66

0.095 (2.08%)

PWFL

PowerFleet

$6.10

0.05 (0.83%)

OSIS

OSI Systems

$100.60

0.63 (0.63%)

LOVE

Lovesac

$10.80

-1.01 (-8.55%)

VERI

Veritone

$2.73

-0.1 (-3.53%)

WTER

Alkaline Water

$1.09

-0.01 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 29

    Jan

PNC

PNC Financial

$158.60

-0.3 (-0.19%)

, PYPL

PayPal

$107.68

2.01 (1.90%)

13:57
12/14/19
12/14
13:57
12/14/19
13:57
Periodicals
PNC clients having trouble connecting to PayPal's Venmo, WSJ reports »

Many of PNC…

PNC

PNC Financial

$158.60

-0.3 (-0.19%)

PYPL

PayPal

$107.68

2.01 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 15

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.